The prevalence of obesity has been increasing during the last 30 years and globally, more than 650 million people have obesity. Obesity is associated with an increased risk of developing type 2 diabetes (T2D), dyslipidemia, hypertension, cardiovascular (CV) disease, obstructive sleep apnea, Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis (NAFLD/NASH), urinary incontinence, several types of cancers, and increased mortality. In addition, individuals with obesity experience reduced health-related quality of life including reduced physical function. Several associations, organizations and individual countries have recognized that obesity should be treated as a chronic disease.
This research study will test the investigational medicine for safety and effectiveness (helping people lose weight) when compared to a medication already approved or to placebo (no active ingredients).
Qualified participants will: